What Is Treatment-Resistant Depression?

If you have tried antidepressants and still feel depressed, you are not broken, and you are not a lost cause. You may be living with what psychiatrists call treatment-resistant depression, or TRD. It is more common than most people realize, it has a clinical definition that can guide the next steps, and importantly, there are effective treatments that work differently from the standard antidepressants you may have already tried.

This article explains what treatment-resistant depression actually is, how it is diagnosed, what causes it, and what your options look like today, including TMS therapy in Pembroke Pines and Spravato esketamine treatment. If you suspect you have TRD and want to talk to a specialist, you can reach treatment-resistant depression care at R&C Psychiatry and Integrative Medicine by calling (954) 872-0555. For authoritative background reading on depression as a diagnosis, the National Institute of Mental Health maintains a thorough patient-facing overview.

What Is Treatment-Resistant Depression?

Treatment-resistant depression is a clinical term used by psychiatrists to describe major depressive disorder that has not responded adequately to at least two different antidepressant medications, each taken at a therapeutic dose for a sufficient duration. The definition focuses on response to treatment, not on how severe or long-standing the depression is. In other words, TRD is not a separate diagnosis in the DSM-5; it is a way of describing where you are in your treatment journey.

The threshold most clinicians and payers use is two or more adequate antidepressant trials from different drug classes, with no full response. Some definitions require partial response; others define TRD by complete non-response. At our clinic, we treat the clinical reality: if standard antidepressants are not getting you to remission, you need a different plan.

How common is TRD? Research suggests that about 30 percent of patients with major depressive disorder will not respond to their first antidepressant, and roughly 30 percent of patients treated with multiple antidepressants remain symptomatic despite multiple trials. That works out to millions of Americans living with some form of treatment-resistant depression at any given time. You are genuinely not alone.

How Do You Know If You Have Treatment-Resistant Depression?

The technical answer is that a psychiatrist confirms TRD by reviewing your treatment history in detail. The practical question most patients ask is, "How do I know my antidepressants are not working well enough?" Some common signs include:

• You still meet criteria for depression despite being on medication for months
• Your symptoms improved initially, then plateaued well short of remission
• You have tried two or more antidepressants without sustained relief
• You feel numb or emotionally flat on medication rather than meaningfully better
• You continue to experience significant sleep disturbance, fatigue, anhedonia, or thoughts of worthlessness despite treatment
• Your depression has interfered with your ability to work, attend school, or maintain relationships

What Counts as an Adequate Trial?

An adequate antidepressant trial is typically defined as:

• The medication was taken at a therapeutic dose, not just a starting dose
• The dose was maintained for at least 4 to 8 weeks, giving the medication enough time to work
• You took the medication consistently as prescribed
• The trial was conducted under medical supervision, with appropriate follow-up

A medication stopped after two weeks because of side effects is not an adequate trial. Neither is a medication taken inconsistently. Many patients come into our office assuming they have tried everything, and on review discover that several of their past trials were cut short. That is clinically meaningful, because it often opens up options that were written off prematurely.

What Causes Treatment-Resistant Depression?

TRD is not one condition with one cause. It is usually a combination of factors, and identifying which factors apply to you is the first step toward a better plan.

Biological factors. Depression involves multiple brain systems, not just serotonin. Some patients have depression that is primarily driven by glutamate dysregulation, neuroinflammation, or disruptions in neuroplasticity. Standard SSRIs and SNRIs target serotonin and norepinephrine, which may not be the primary driver for every patient. This is one reason newer treatments such as Spravato, which targets the NMDA glutamate receptor, can work when serotonergic antidepressants have not.

Misdiagnosis. Some patients labeled as having treatment-resistant depression actually have bipolar depression, which does not respond as well to SSRIs alone and often requires mood stabilizers or antipsychotics. Others have depression complicated by ADHD, trauma, or a substance use disorder. A thorough psychiatric reassessment sometimes reveals that the issue is not resistance but a diagnosis that calls for a different treatment approach.

Underlying medical conditions. Thyroid disorders, vitamin deficiencies (particularly B12 and D), sleep apnea, chronic pain, and hormonal imbalances can all cause or worsen depressive symptoms. When these are missed, it can look like antidepressants are failing when the real issue is untreated medical comorbidity.

Psychosocial factors. Ongoing trauma, grief, chronic stress, lack of social support, and unresolved relationship or financial stressors can blunt the effect of medication. Medication is powerful, but it cannot rewrite the circumstances of your life. For many patients, combining medication with therapy produces results that medication alone cannot.

What Are the Treatment Options?

This is where the news gets good. Over the last decade, the field of psychiatry has developed several effective options specifically for patients who have not responded to standard antidepressants.

TMS Therapy

Transcranial magnetic stimulation (TMS) is a non-invasive, non-medication treatment that uses focused magnetic pulses to stimulate the dorsolateral prefrontal cortex, a brain region involved in mood regulation. Over a course of sessions, TMS helps restore healthy activity in underactive brain circuits and promotes neuroplasticity. It has been FDA cleared for treatment-resistant depression since 2008, with expanded clearances for anxious depression and OCD.

At R&C Psychiatry, we use Exomind, a next-generation TMS platform developed by BTL. Exomind offers the same mechanism as traditional TMS but with several patient-facing advantages: sessions of under 30 minutes rather than 40 to 60, a core course of as few as 6 sessions rather than 30 to 40, and a trapezoid waveform that is generally more comfortable than standard pulses. For many patients with TRD, Exomind makes it possible to complete a full course of neuromodulation without putting life on hold for two months. TMS is a strong option when medication side effects have been intolerable, when you want to reduce medication burden, or when you simply want to try something that works through a completely different mechanism.

Spravato (Esketamine)

Spravato is an FDA-approved nasal spray for treatment-resistant depression. Its active ingredient, esketamine, is derived from ketamine and works on a completely different system than SSRIs or SNRIs. Rather than targeting serotonin, Spravato acts on the NMDA glutamate receptor, producing rapid changes in synaptic activity and neuroplasticity.

The practical difference is speed. Standard oral antidepressants can take four to six weeks to reach full effect. Spravato can produce noticeable mood improvement within hours to days for many patients, with benefits that continue to build over a structured treatment course. It is administered in a certified clinic under provider supervision because of a two-hour observation period after each dose. For patients who have cycled through multiple antidepressants without relief, Spravato offers a different pharmacological lever that often succeeds where traditional antidepressants have not.

Medication Augmentation and Optimization

Sometimes the answer is not a new treatment but a smarter medication strategy. Augmentation refers to adding a second medication that complements your existing antidepressant. Common augmenting agents include low-dose atypical antipsychotics (such as aripiprazole or brexpiprazole) approved as add-on therapies for major depression, lithium in select cases, thyroid hormone augmentation, and carefully chosen combinations of antidepressants from different drug classes. A thorough medication review with a psychiatrist can reveal opportunities that have not yet been tried.

An Integrative Psychiatric Approach

At R&C Psychiatry, we take an integrative approach to TRD. That means looking at the whole picture: medication, neuromodulation, psychotherapy, sleep, nutrition, and any medical conditions that may be contributing. Depression that has resisted multiple treatment attempts rarely responds to a single-modality fix. Our team combines psychiatric prescribers with therapists under one roof, so the plan can be coordinated and adjusted as you go. For the right patient, that coordinated plan may include Spravato to create rapid relief while starting TMS for durable long-term change, along with therapy to address the life factors that have kept depression in place.

Can Treatment-Resistant Depression Be Cured?

The honest answer is that most chronic depression, like most chronic medical conditions, is better described in terms of remission than cure. Remission means your symptoms have improved to the point that you no longer meet criteria for depression and your functioning has returned to what feels normal for you. Many patients with TRD do achieve remission, and many maintain it for long periods with ongoing care.

Cure, meaning permanent freedom from any future depressive episode, is a stronger claim that psychiatry cannot responsibly promise. What we can say is that studies suggest a substantial proportion of patients with TRD who try TMS, Spravato, or well-designed augmentation strategies experience meaningful and often lasting improvement. For some patients, that improvement is complete enough that depression fades into the background of their lives.

When to Seek Specialist Help

It is reasonable to seek specialist care if any of the following apply:

• You have tried two or more antidepressants without full response
• You feel stuck on a medication that is only partially working
• Side effects have made medication intolerable
• Your depression is affecting your ability to work, parent, or maintain relationships
• You have thoughts of self-harm or suicide (if these are active, call or text 988 for the Suicide and Crisis Lifeline, or go to the nearest emergency department)
• Your primary care provider has recommended a psychiatric specialist

A psychiatric consultation with a provider who offers TMS, Spravato, and advanced medication strategies is different from a general medication check. It is a full reassessment of your diagnosis, treatment history, and options, with the goal of building a plan that fits where you actually are rather than starting over from scratch.

Frequently Asked Questions

How many antidepressants do I need to try before I am considered treatment-resistant?

The most common clinical threshold is two or more adequate antidepressant trials from different drug classes without full response. "Adequate" means the medication was taken at a therapeutic dose for at least 4 to 8 weeks. Your psychiatrist will review your history in detail to determine whether your past trials meet the threshold, which matters because it can affect insurance coverage for advanced treatments such as TMS and Spravato.

Is treatment-resistant depression the same as bipolar disorder?

No. Treatment-resistant depression is a description of how unipolar major depressive disorder has responded to treatment. Bipolar disorder is a separate diagnosis involving both depressive episodes and periods of elevated, irritable, or manic mood. That said, bipolar depression is sometimes initially misdiagnosed as treatment-resistant depression because standard antidepressants do not work well for it. A careful reassessment can distinguish the two and often points to a treatment plan (including mood stabilizers or specific atypical antipsychotics) that addresses the real diagnosis.

Can TMS therapy help treatment-resistant depression?

Yes. TMS is FDA cleared specifically for treatment-resistant depression and for anxious depression. Studies suggest that TMS produces meaningful improvement in a substantial proportion of patients who have not responded to two or more antidepressants, with many achieving remission. At R&C Psychiatry we use Exomind, a modern TMS platform with shorter sessions and a shorter overall course than older systems.

Is Spravato only for treatment-resistant depression?

Spravato is FDA approved for two indications: treatment-resistant depression in adults, and depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, when used in combination with an oral antidepressant. In other words, it is not approved as a first-line treatment but is specifically designed for patients whose depression has been difficult to treat with standard antidepressants. Insurance coverage typically requires documentation of prior failed antidepressant trials.

Does treatment-resistant depression ever go away?

Many patients with TRD achieve remission, meaning their symptoms improve enough that depression no longer interferes with daily life. For some patients that remission is long-lasting; for others it requires ongoing maintenance treatment, similar to how chronic medical conditions such as diabetes or high blood pressure are managed. Advances in TMS, Spravato, and augmentation strategies have changed the outlook considerably over the last decade. If standard antidepressants have not worked for you, that does not mean nothing will.

Ready for a Different Plan?

If you think you may have treatment-resistant depression and you are ready for a plan that goes beyond another SSRI, R&C Psychiatry and Integrative Medicine in Pembroke Pines, FL offers a full range of advanced options, including Exomind TMS, Spravato, and coordinated integrative care. Call (954) 872-0555 or book a consultation online. We serve patients across Broward and Miami-Dade counties and welcome new patients in English and Spanish.